Payments to Health Care Trust Funds
Schedules
TAFS: 075-0580 /2022 - Payments to Health Care Trust Funds
Previously Approved (Iteration 2) | Current OMB Action (Iteration 3) | |||||
---|---|---|---|---|---|---|
Line # | Split | Description | Amount | Footnotes | Amount | Footnotes |
1200 | 1 | BA: Mand: Appropriation | $152,924,358.00 | $152,924,358.00 | ||
1201 | BA: Mand: Appropriation (special or trust) | $487,862,000,000.00 | $497,862,000,000.00 | |||
1920 | Total budgetary resources avail (disc. and mand.) | $488,014,924,358.00 | $498,014,924,358.00 | |||
6011 | FBI Fraud and Abuse Control Activities | $152,924,358.00 | $152,924,358.00 | |||
6012 | Supplementary Medical Insurance | $384,646,000,000.00 | $384,646,000,000.00 | |||
6013 | Medicare Prescription Drug Benefit | $100,968,883,000.00 | $110,968,883,000.00 | |||
6014 | Medicare Prescription Drug Benefit Admin | $882,000,000.00 | $882,000,000.00 | |||
6015 | Hospital Insurance Uninsured - Federal | $82,000,000.00 | $82,000,000.00 | |||
6016 | Program Management Admin Expenses | $929,000,000.00 | $929,000,000.00 | |||
6017 | Reimburse HCFAC Discreationary | $349,117,000.00 | $349,117,000.00 | |||
6018 | State Low Income Determination | $5,000,000.00 | $5,000,000.00 | |||
6190 | Total budgetary resources available | $488,014,924,358.00 | $498,014,924,358.00 | |||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
No footnotes available.
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.